跳至主要内容
临床试验/NCT04838223
NCT04838223
暂停
不适用

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Tufts Medical Center30 个研究点 分布在 1 个国家目标入组 1,000 人2021年7月2日

概览

阶段
不适用
干预措施
Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Optional; only for Contact Lens Wearers
疾病 / 适应症
Dry Eye
发起方
Tufts Medical Center
入组人数
1000
试验地点
30
主要终点
To establish the prevalence of neuropathic corneal pain in patients with ocular surface discomfort.
状态
暂停
最后更新
3个月前

概览

简要总结

This study is designed to measure how common nerve abnormalities are within a group of patients who feel discomfort within their eyes.

注册库
clinicaltrials.gov
开始日期
2021年7月2日
结束日期
2026年7月1日
最后更新
3个月前
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Presents with ocular surface discomfort or for dry eye care
  • Best corrected visual acuity of 20/40 or better in each eye
  • Subject reported duration of symptoms of at least 3 months
  • 100 subjects will be required to be habitual contact lens wearers as defined by use of contact lenses at least 5 hours per day at least 5 days per week for the last year.

排除标准

  • Use of contact lenses on the day of the visit
  • Pregnant or nursing
  • Irregular corneas (e.g., ectatic disease, transplantation, or corneal dystrophies)
  • Ocular surgery in the past 3 months
  • Ocular infection in the past 3 months
  • Active ocular allergies

研究组 & 干预措施

Neuropathic Corneal Pain with Dry Eye Disease

Participants diagnosed with dry eye disease and neuropathic corneal pain

干预措施: Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Optional; only for Contact Lens Wearers

Neuropathic Corneal Pain with Ocular Surface Discomfort

Participants diagnosed with neuropathic corneal pain with ocular surface discomfort

干预措施: Hyperosmolar Response

Neuropathic Corneal Pain with Ocular Surface Discomfort

Participants diagnosed with neuropathic corneal pain with ocular surface discomfort

干预措施: Proparacaine Challenge Test

Neuropathic Corneal Pain with Ocular Surface Discomfort

Participants diagnosed with neuropathic corneal pain with ocular surface discomfort

干预措施: Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Optional; only for Contact Lens Wearers

Neuropathic Corneal Pain with Ocular Surface Discomfort

Participants diagnosed with neuropathic corneal pain with ocular surface discomfort

干预措施: Ocular Pain Assessment Survey (OPAS)

Neuropathic Corneal Pain with Ocular Surface Discomfort

Participants diagnosed with neuropathic corneal pain with ocular surface discomfort

干预措施: Visual Analogue Questionnaire

Neuropathic Corneal Pain with Dry Eye Disease

Participants diagnosed with dry eye disease and neuropathic corneal pain

干预措施: Hyperosmolar Response

Neuropathic Corneal Pain with Dry Eye Disease

Participants diagnosed with dry eye disease and neuropathic corneal pain

干预措施: Proparacaine Challenge Test

Neuropathic Corneal Pain with Dry Eye Disease

Participants diagnosed with dry eye disease and neuropathic corneal pain

干预措施: Ocular Pain Assessment Survey (OPAS)

Neuropathic Corneal Pain with Dry Eye Disease

Participants diagnosed with dry eye disease and neuropathic corneal pain

干预措施: Visual Analogue Questionnaire

NCP or Dry Eye in patients with ocular surface discomfort

Participants diagnosed with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort

干预措施: Hyperosmolar Response

NCP or Dry Eye in patients with ocular surface discomfort

Participants diagnosed with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort

干预措施: Proparacaine Challenge Test

NCP or Dry Eye in patients with ocular surface discomfort

Participants diagnosed with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort

干预措施: Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Optional; only for Contact Lens Wearers

NCP or Dry Eye in patients with ocular surface discomfort

Participants diagnosed with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort

干预措施: Ocular Pain Assessment Survey (OPAS)

NCP or Dry Eye in patients with ocular surface discomfort

Participants diagnosed with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort

干预措施: Visual Analogue Questionnaire

结局指标

主要结局

To establish the prevalence of neuropathic corneal pain in patients with ocular surface discomfort.

时间窗: Day 1

As measured by the percent of subjects who report increased ocular surface discomfort upon challenge with hyperosmolar saline.

To establish the prevalence of subtypes of patients with neuropathic corneal pain or with a neuropathic component of dry eye in patients with ocular surface discomfort.

时间窗: Day 1

As measured by the percent of subjects who report ocular surface discomfort, and have a decrease, partial decrease, or no change in Visual Analog Score score upon instillation of proparacaine.

To assess the overlap of neuropathic corneal pain with dry eye disease in patients in diseases that are currently thought to be mutually exclusive.

时间窗: Day 1

As measured by the percent of subjects who report ocular surface discomfort, and either do or do not exhibit signs of dry eye disease as defined by Tear Break Up Time, Schirmer's test, and staining, and have an increase in Visual Analog Scale score of more than 2 steps upon instillation of hypertonic saline.

次要结局

  • To establish the prevalence of anxiety/depression in patients with neuropathic corneal pain patients.(Day 1)
  • To assess the overlap of neuropathic corneal pain and contact lens discomfort.(1 study visit)
  • To assess for differences in in vivo confocal microscopy measures between dry eye disease patients and neuropathic corneal pain patients.(Day 1)
  • To assess for subtypes of neuropathic corneal pain differences in in vivo confocal microscopy measures between dry eye disease patients and neuropathic corneal pain patients.(Day 1)

研究点 (30)

Loading locations...

相似试验